-
Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 04/02/25 )
NAV
₹29.71
Last change
₹0.44 +0.02%
Fund Size (AUM)
1287.45 Cr
Performance
25.13% (5Y)
Fund Details
Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl
as of 04/02/25
AUM
1287.45 Cr
Expense Ratio
2.13 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K018A5
Fund Manager
Meeta Shetty
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl | 22.71% | 19.3% | 25.13% |
| Nifty Pharma TR INR | 23.62% | 20.15% | 24.53% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.78% |
Aurobindo Pharma Ltd |
7.68% |
Lupin Ltd |
7.51% |
Dr Reddy's Laboratories Ltd |
6.63% |
Cipla Ltd |
5.82% |
Divi's Laboratories Ltd |
4.97% |
Fortis Healthcare Ltd |
4.78% |
Zydus Lifesciences Ltd |
3.56% |
Apollo Hospitals Enterprise Ltd |
3.34% |
Alkem Laboratories Ltd |
3.29% |
Sector Allocation
Healthcare |
97.83% |
Basic Materials |
2.17% |
Asset Allocation
-
95%
Equity
-
5%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
27.54% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
27.54% (5Y)
-
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
28.38% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
25.56% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
27.61% (5Y)
-
-
Nippon India Pharma IDCW-R
Equity healthcare-
Returns
-
27.76% (5Y)
-
